注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Soligenix Inc是一家后期生物制药公司。该公司专注于开发治疗罕见疾病的产品。该公司通过两个部门运营:专业生物治疗和公共卫生解决方案。专业生物治疗部门包括开发HyBryte(SGX301或合成金丝桃素)一种用于治疗皮肤T细胞淋巴瘤(CTCL)的光动力疗法。公共卫生解决方案部门包括RiVax,以防止暴露于蓖麻毒素疫苗候选疫苗和SGX943治疗候选抗生素耐药性和传染病。该公司的开发项目包括天然防御调节剂(IDR)技术、用于治疗炎症性疾病、头颈癌口腔粘膜炎的杜斯奎特(SGX942)以及用于预防/治疗胃肠道疾病(包括儿童克罗恩病(SGX203))的口服倍氯米松17,21-二丙酸酯(BDP)。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Mark Schubert | - | - | Member of Oral Mucositis Medical Advisory Board |
James Markowitz | - | - | Member of Pediatric Crohn's Disease Medical Advisory Board |
Gary Wood | - | - | Member of Cutaneous T-Cell Lymphoma Medical Advisory Board |
Christopher J. Schaber | 58 | 2006 | Chairman of the Board of Directors, CEO & President |
W. Joost Wiersinga | - | - | Member of Melioidosis Scientific Advisory Board |
Gregory Anthony Lapointe | 65 | 2009 | Independent Director |
Alain H. Rook | - | - | Member of Cutaneous T-Cell Lymphoma Medical Advisory Board |
Jeffrey Hyams | - | - | Member of Pediatric Crohn's Disease Medical Advisory Board |
Joel Rosh | - | - | Member of Pediatric Crohn's Disease Medical Advisory Board |
Bart Currie | - | - | Member of Melioidosis Scientific Advisory Board |
Yusuf Yazici | - | 2024 | Member of Behcet's Disease Medical Advisory Board |
Direk Limmathurotsakul | - | - | Member of Melioidosis Scientific Advisory Board |
Andrew Sulich | - | 2024 | Member of Behcet's Disease Medical Advisory Board |
Robert J. Rubin | 78 | 2009 | Independent Director |
Dorothy Mary Kate Keefe | - | - | Member of Oral Mucositis Medical Advisory Board |
Jerome Bernard Zeldis | 74 | 2011 | Independent Director |
Youn Kim | - | - | Member of Cutaneous T-Cell Lymphoma Medical Advisory Board |
Madeleine Duvic | - | - | Member of Cutaneous T-Cell Lymphoma Medical Advisory Board |
David AB Dance | - | - | Member of Melioidosis Scientific Advisory Board |
Diane L. Parks | 72 | 2019 | Independent Director |
Johannes Nowatzky | - | 2024 | Member of Behcet's Disease Medical Advisory Board |
Gülen Hatemi | - | 2024 | Member of Behcet's Disease Medical Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核